An Actinobacillus succinogenes plasmid vector which provides a means to overexpress proteins in A. succinogenes. The plasmid can be transformed efficiently by electroporation, and replicates in a stable manner in A. succinogenes. The plasmid comprises at least one marker gene, operably linked to a first promoter functional in Actinobacillus succinogenes, an origin of replication functional in Actinobacillus succinogenes, a second promoter isolated from Actinobacillus succinogenes, and a cloning site downstream from the second promoter. Plasmids pLGZ901, pLGZ920, pLGZ921, and pLGZ922 are disclosed. The pckA gene polypeptide sequence and nucleic acid sequence of Actinobacillus succinogenes, including the promoter and ribosome binding site, is disclosed. Furthermore, a method for producing a recombinant Actinobacillus succinogenes is described, including a method of transformation. Additionally, a recombinant Actinobacillus succinogenes is disclosed and a method for producing succinate utilizing this recombinant Actinobacillus succinogenes is described.
1. A plasmid comprising:
(a) at least one marker gene comprising a Tn3 Amp R gene, or an ampicillin, tetracycline or chloramphenicol resistance gene operably linked to a first promoter comprising one or more pairs of −35 and −10 promoter elements of an Actinobacillus succinogenes pckA gene;
(b) an origin of replication comprising at least a 1.5 kB PstI-HaeII fragment of a pGZRS-1 replicon so as to be functional in Actinobacillus succinogenes;
c) a second promoter comprising one or more pairs of −35 and −10 elements of the Actinobacillus succinogenes pckA gene; and
(d) a cloning site downstream from the second promoter.
2. The plasmid of claim 1 wherein the second promoter comprises the nucleic acid sequence set forth in SEQ ID NO: 21 from between about nucleotide 25 and nucleotide 255.
3. The plasmid of claim 1 wherein the second promoter provides a ribosome binding site comprising the nucleotide sequence AGGTG.
4. The plasmid of claim 1 further comprising a ColE1 origin of replication.
5. The plasmid of claim 1 wherein the cloning site comprises one or more restriction endonuclease cleavage sites.
6. A plasmid which is pLGZ901.
7. A plasmid which is pLGZ920, deposited as ATCC PTA 6140.
8. An isolated nucleic acid which comprises the nucleotide sequence set forth in SEQ ID NO: 21.
9. A recombinant Actinobacillus succinogenes comprising:
a plasmid capable of autonomous replication in the Actinobacillus succinogenes which comprises
(a) at least one selectable marker gene comprising a Tn3 Amp R gene, or an ampicillin, tetracycline or chloramphenicol resistance gene operably linked to a promoter comprising one or more pairs of −35 and −10 promoter elements of an Actinobacillus succinogenes pckA gene;
(b) an origin of replication comprising at least a 1.5 kB PstI-HaeII fragment of a pGZRS-1 replicon so as to be functional in Actinobacillus succinogenes ; and
c) the Actinobacillus succinogenes pckA gene.
10. The recombinant Actinobacillus succinogenes of claim 9 wherein the pckA gene comprises the nucleic acid sequence set forth in SEQ ID NO: 21.
11. The recombinant Actinobacillus succinogenes of claim 9 wherein the plasmid is pLGZ902.
12. A recombinant microorganism comprising the nucleic acid which comprises the nucleotide sequence set forth in SEQ ID NO: 21.
13. A plasmid which is pLGZ921.
14. A plasmid which is pLGZ922.